Last month CML participated in RFMW’s Annual NA and European Sales Conference. This was a great opportunity to spend a lot of time with th...
December 2020: Liam Devlin answers questions from Microwave Product Digest in the 2021 edition of its annual “View from the Top” feature. Topics include RF digitalisation, 5G open architectures and keeping business going during the pandemic. Click here to read the article. Fabs and Labs feature...
Conference|ASH Annual Meeting and Exposition Olverembatinib was found to uphold clinical benefit and continued to have an acceptable safety profile in patients with BCR-ABL1 T315I-mutant chronic myeloid leukemia -chronic phase or -acute phase that is resistant to TKIs. Olverembatinib (HQP...
会议名称: ISMPO Annual Conference- 2012 会议时间: 2012/02/11 收藏 引用 批量引用 报错 分享 全部来源 求助全文 ResearchGate 相似文献Malignancies occurring during therapy with tyrosine kinase inhibitors (TKIs) for chronic myeloid leukemia (CML) and other hematologic malignancies Second cancers occur in ...
Looking to the 29th Annual International Congress on Hematologic Malignancies®: Focus on Leukemias, Lymphomas, and Myeloma, being held from February 25 to March 2, 2025, in Miami Beach, Florida, Cortes, who is also cochair, emphasized that the mix of the most current dat...
Conferences Conference CoverageConference Listing Events Giants of Cancer CareCME/CEScientific InterchangesState of the Science Summit / IPCNational Fellows ForumWebinars PartnersPublications Resources Consensus ViewpointsInteractive ToolsSponsored Biomarker ConsortiumSubscribe ...
13 Allogeneic stem cell transplantation should be considered in patients with disease resistant to ponatinib and even in those who are taking ponatinib (but facing challenges such as toxicities or high annual cost of therapy). In summary, a careful evaluation of the reason to modify ...
Conference|ASCO Annual Meeting: Hematology Findings from the phase 3 ASCEMBL trial indicated that asciminib as a treatment for chronic myelogenous leukemia in chronic phase could represent a new standard of care. Patients with chronic myelogenous leukemia in chronic phase (CML-CP) who have been ...